Literature DB >> 21086930

Effectiveness of the cavus foot orthosis.

Matteo LoPiccolo1, Margaret Chilvers, Brain Graham, Arthur Manoli.   

Abstract

This study investigated the use of a custom cavus foot orthosis (CFO) in the treatment of ankle instability and pain associated with the subtle cavus foot, a common pathological foot alignment in the United States population. Patients referred by a single orthopedic foot and ankle surgeon to a single pedorthotist for a CFO over a 2-year period were eligible. Pain score pre-and postorthosis and number of instability events pre- and postorthosis were retrospectively evaluated. Ninety-three of 174 eligible patients participated. Average age was 48 years (range, 20-75) and patients suffered a variety of foot pathologies. Average pre-CFO pain score was 7.22 (0 no pain, 10 worst pain). Post-CFO pain score average was 2.41 (p < .0005). Ninety-two percent of patients reporting ankle instability as a problem experienced a decrease in the frequency of instability events post-CFO. The custom cavus foot orthosis is effective at relieving pain and reducing ankle instability in the patient with the subtle cavus foot alignment.

Entities:  

Mesh:

Year:  2010        PMID: 21086930

Source DB:  PubMed          Journal:  J Surg Orthop Adv        ISSN: 1548-825X


  3 in total

1.  Evaluation of Asymptomatic Contralateral Foot Deformities Using the Tripod Index.

Authors:  Courtney Carlson; Craig Akoh; Chamnanni Rungprai; Phinit Phisitkul
Journal:  Iowa Orthop J       Date:  2019

Review 2.  Reconstruction of Cavus Foot: A Review.

Authors:  Bom Soo Kim
Journal:  Open Orthop J       Date:  2017-07-31

3.  Immediate and short-term radiological changes after combining static stretching and transcutaneous electrical stimulation in adults with cavus foot: A randomized controlled trial.

Authors:  Lourdes María Fernández-Seguín; Alberto Marcos Heredia-Rizo; Juan Antonio Díaz-Mancha; Paula González-García; Javier Ramos-Ortega; Pedro V Munuera-Martínez
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.